Course Preview

Disciplines: Pharmacy
Hours: 2 Contact Hours
Author(s): Cheryl Durand, PharmD
Peer Reviewer(s):
  • Melissa J. Durham, PharmD, MACM, BCACP, DAIPM
  • Abimbola Farinde, PharmD
Item#: Y8045
Contents: 1 Course Book (40 pages)
Sign up for the Western Schools 365 Online Membership

A Review of Commonly Prescribed Antibiotics: Back to Basics

Price $8.95
Item # Y8045
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Release Date: November 20, 2018

Expiration Date: November 30, 2021

Antibacterial therapy offers many choices. Guidelines help clinicians make the optimal antibiotic choice for treatment of specific infectious diseases, but recommended treatment options can change with the development of antimicrobial resistance and the introduction of newer agents. Pharmacists must maintain updated knowledge about antibiotics, including spectrum of activity, therapeutic uses, ADRs, and drug interactions. This course covers commonly used antibiotics, serving as a refresher on mechanism of action; spectrum of activity; common clinical uses, resistance mechanisms, ADRs and drug interactions; and patient counseling points.


Universal Activity Number (UAN) - 0607-0000-18-055-H04-P

Type of Activity - Knowledge

Topic Designatior - 04 General Pharmacy

Course Objectives

  • Identify issues with antibiotic use and misuse.
  • Identify the mechanism of action of commonly prescribed antibiotics.
  • Identify uses for commonly prescribed antibiotics.
  • List common or serious adverse drug reactions (ADRs) and drug interactions for commonly prescribed antibiotics.
  • Recall patient education for commonly prescribed antibiotics.

Cheryl Durand, PharmD, is an associate professor of pharmacy practice at Massachusetts College of Pharmacy and Health Science (MCPHS) with a focus on infectious disease and pharmacy advocacy and leadership. Dr. Durand graduated from Northeastern University. At MCPHS, she is a preceptor for institutional advanced phar­macy practice experience students, and her practice site is Elliot Hospital in Manchester, New Hampshire. She serves as a member on the New Hampshire Board of Pharmacy Continuing Education Advisory Council and has been an executive board member of the New Hampshire Pharmacists Association since 2005; she is currently the vice president of the association. Dr. Durand is also a recipient of the 2014 Trustees’ Award for Teaching Excellence at MCPHS. Before joining MCPHS in 2007, she spent several years as a clinical pharmacist and clini­cal pharmacy manager in different hospital settings. In July 2017, Dr. Durand was appointed as the vice chair for the Pharmacy Practice Department at MCPHS School of Pharmacy Worcester/Manchester.

Melissa J. Durham, PharmD, MACM, BCACP, DAIPM, is an assistant professor of clinical pharmacy at the University of Southern California (USC) School of Pharmacy. She received her doctor of pharmacy degree, completed a residency in community pharmacy practice, and has earned her master’s degree in academic medicine, all from USC. Dr. Durham is a clinical pharmacist at the USC Pain Center in the Department of Anesthesiology, where she established a pharmacist-run pain medication management service. She is a board-certified ambulatory care pharmacist and a diplomat of the Academy of Integrative Pain Management.

Abimbola Farinde, PharmD, is a clinical pharmacy specialist who has gained experience in the field and practice of psychopharmacology/mental health and geriatric pharmacy.

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.